Centene Posts $3.37 EPS, Raises Full-Year Outlook Above $3.40
Centene delivered Q1 adjusted EPS of $3.37, beating forecasts and raised its full-year 2026 EPS target to over $3.40. The insurer generated $44.7 billion of premium revenue, improved Medicaid HBR to 93.1% and reduced its debt-to-cap ratio to 43.2% by quarter-end.
1. Q1 Earnings Beat and Outlook Raise
Centene reported adjusted diluted EPS of $3.37 for Q1, surpassing consensus, and increased its full-year 2026 EPS outlook to over $3.40 from over $3. This beat was driven by outperformance in Medicare Advantage and favorable SG&A.
2. Membership and Margin Improvement
Premium and service revenues reached $44.7 billion in Q1 as Medicaid membership grew to 12.4 million and marketplace enrollees to 3.58 million. Medicaid HBR improved to 93.1%, up 50 basis points year-over-year, while consolidated HBR stood at 87.3%.
3. Cash Flow and Debt Reduction
The company generated $4.4 billion in operating cash flow and lowered its debt-to-cap ratio to 43.2% from 46.5% at year-end 2025. Medical claims liabilities totaled $20.6 billion, equivalent to 48 days in claims payable.
4. Cautious Forward Guidance and Risks
Centene signaled a sequential earnings step-down through Q2 to Q4 due to seasonality and elevated behavioral health and high-cost drug trends. It also faces substantial debt maturities in 2027 and 2028 which may require refinancing at higher rates.